Becker's Healthcare December 2, 2024
Jakob Emerson

The prices for some GLP-1s have dropped significantly in recent years for individuals covered by Medicare and commercial insurance, according to a new report from HHS.

In 2024, the U.S. list prices for a one-month supply for most GLP-1s are stable or increasing, but after payer negotiations and rebates, net prices for many GLP-1s have decreased since 2022. Net prices for GLP-1s are between 24% and 73% lower than list prices, indicating that most insurers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Pharma / Biotech
Employer Group Medicare Advantage Membership Trends by Mark Farrah Associates
Prior Authorization in 2025: Key Trends Shaping the Future of Health Care
Top 10 Healthcare Industry Predictions For 2025
Will weight-loss drugs soon be covered by Medicare and Medicaid?
As California goes (on AI)...

Share This Article